Final-Program-ATS-2023-AP.vp

174

MONDAY • MAY 22

P9 Associations of Institutional COVID-19 Mortality and Bacillus Calmette Guerin in Tikur Anbessa Specialized Hospital COVID-19 Treatment Center, Addis Ababa, Ethiopia/ B.W. Haile, Addis Ababa, Ethiopia P10 Hyperoxemia as an Additional Source of Systemic Injury in Coronavirus Disease 2019 (COVID-19) Patients/ I.Y. Valencia, Houston, TX P11 Relation Between Baseline Asthma Treatment and COVID-19: Evaluating the Data in National Medical Center in Japan/ A. Tsukada, Tokyo, Japan P12 Does Remdesivir Increase the Risk of Pneumothorax in COVID-19 Infected Patients/ R. Smidy, Brooksville, FL P13 Demographics and Outcomes of Young Adults Admitted With Coronavirus Disease 2019 (COVID-19)/ C. Villarreal-Carrillo, Houston, TX P14 Radiological and Pulmonary Function Abnormalities in Post COVID Patients- a Prospective Cohort Study/ A. Krishnan, Varanasi, India P15 Impact of Positive Sputum Cultures on Outcomes in Mechanically Ventilated Coronavirus Disease 2019 (COVID-19) Patients/ V. Gomez, Houston, TX P16 Association of Clinical and Imaging Characteristics With Pulmonary Function Testing in Patients With Long-COVID/ A.C. Lancaster, Baltimore, MD P17 Outcomes in Patients Who Received Toculizumab for SARS-CoV-2 Acute Respiratory Distress Syndrome/ P. Bergin, Dublin, Ireland P18 Acute Cerebrovascular Events Associated With COVID-19 Infection in Multi-ethnic Population in Hawaii/ P. Shah, Honolulu, HI P19 Magnitude and Characteristics of COVID 19 Among Patients With Hematologic Malignancy at Tikur Anbessa Specialized Hospital, Addis Ababa, Ethiopia/ A.Y. Ashamo, Addis Ababa, Ethiopia P20 The Impact of COVID-19 Vaccination on Disease Severity at a Teaching Hospital in Depok, Indonesia/ N. Salsabila, Jakarta, Indonesia P21 Could Thromboelastography (TEG) Improve Outcomes for Critically Ill COVID-19 Patients: An Exploratory Observational Study/ S.M. Duenas, Manhasset, NY P22 Combination Treatment of Molnupiravir With Sotrovimab for COVID-19 Patients in Japan/ M. Seki, Hidaka City, Japan P23 Impact of Aspergillus Infection on Prognosis in Severe COVID-19 Patients/ S. Kamimoto, Tochigi, Japan P24 Elucidating a Potential Relationship Between a

P238 Low Cholesterol and Right Ventricular Function in Pulmonary Hypertension/ B.F. Fakhry, Cleveland, OH P239 Evaluating the Impact of a Pulmonary Hypertension Task Force at a Single Urban Center/ A.S. Saini, New York, NY P240 Single Cell RNA Sequencing Reveals Novel Endothelial and Mesenchymal Cellular Interactions and Cellstate Transitions in TNF-mediated Pulmonary Arterial Hypertension/ S. Bhattacharya, Rochester, NY P241 The Impact of COVID-19 Extracellular Vesicles on Pulmonary Vascular Dysfunction in Diabetic Rats/ A. Kumar, Kansas City, KS

BASIC • CLINICAL • TRANSLATIONAL THEMATIC POSTER SESSION

B61

MORE OF COVID-19

9:00 a.m. - 4:15 p.m.

Walter E. Washington Convention Center Area A, Hall C (Lower Level)

Viewing: Posters will be on display for entire session

11:30-1:15

Discussion: 11:30-12:15 authors will be present for individual discussion

12:15-1:15 authors will be present for discussionwith assigned facilitators. A Retrospective Study of the Effect of Ronapreve (Casirivimab and Imdevimab) Treatment on the Outcomes of Hospitalised COVID-19 Patients in a UK District General Hospital/ E. Mahon, Telford, United Kingdom Compared to the Wuhan Variant, Infection With Omicron and Delta Variants of SARS-CoV-2 Are Associated With Decreased Odds of Developing Post-Acute Sequelae of COVID-19/ J. Bailey, Chicago, IL Evidence That N95 Respirators Should Become the Standard for Source Control of SARS-CoV-2 and Other Respiratory Pathogens/ D.K. Milton, College Park, MD DOCK2 Is Involved in the Host Genetics and Biology of Severe COVID-19/ H. Namkoong, Tokyo, Japan Sequential Analysis of Bronchoalveolar Lavage Proteins Associated With Coagulation in Patients With SARS-CoV2 Infection/ Z.M. Htun, Baltimore, MD Male Gender Is Independently Associated With Poor Outcomes in COVID-19 Hospitalizations: A National Inpatient Sample Study/ Z. Abdalla, Sharjah, United Arab Emirates Radiographic and Clinical Corellations in Survivors With Post -ARDS Related to COVID-19 Two Years After Discharge From Hospitals/ A.S. Sadigov, Baku, Azerbaijan C Reactive Protein and Frailty in COVID-19/ J.K. Graham, San Diego, CA

P1

P2

P3

P4

P5

P6

P7

P8

Preexisting History of Asthma and Longitudinal Pulmonary Symptoms After COVID-19 Infection/ J.E. Dobbs, Washington, DC

ATS 2023 • Washington, DC